Generalized immune activation in pulmonary tuberculosis: Co-activation with HIV infection

Clinical and Experimental Immunology

Volumn 103, Issue 1, 1996, Pages 30-34

  Vanham, G ^e   Edmonds, K ^a   Qing, L ^a   Hom, D ^a   Toossi, Z ^a   Jones, B ^b   Daley, C L ^c   Huebner, R ^d   Kestens, L ^e   Gigase, P ^e   Ellner, J J ^a,f  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^f CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

FC receptor; HIV; HLA DR; Immune activation; Tuberculosis

Indexed keywords

BETA 2 MICROGLOBULIN; CYTOKINE; FC RECEPTOR; HLA DR ANTIGEN; NEOPTERIN;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MALE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 9044223648     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.907600.x     Document Type: Article

References (46)

1. Barnes PF, Modlin RL, Eliner JJ. T-cell responses and cytokines. In: Bloom BR, ed. Tuberculosis: pathogenesis, protection and control. Washington DC: American Society for Microbiology, 1994: 417-35.
2. Ellner JJ, Spagnuolo PJ, Schacter BZ. Augmentation of selective monocyte functions in tuberculosis. J Infect Dis 1981; 144:391-8.
3. Ellner JJ. Immunology of human tuberculosis. Perspectives for vaccine development. Chest 1989; 95:237S-40S.
4. Ellner JJ. Suppressor adherent cells in human tuberculosis. J Immunol 1978; 121:2573.
5. Toossi Z, Edmonds K, Tomford JW, Ellner JJ. Suppression of purified protein derivative-induced interleukin-2 production by interaction of CD16 (Leu 11 reactive) lymphocytes and adherent mononuclear cells in tuberculosis. J Infect Dis 1989; 159:352-6.
6. Toossi Z, Sedor JR, Lapurga JP, Ondash RJ, Ellner JJ. Expression of functional interleukin 2 receptors by peripheral blood monocytes from patients with active pulmonary tuberculosis. J Clin Invest 1990; 85:1777-84.
7. Toossi Z, Kleinhenz ME, Ellner JJ. Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis. J Exp Med 1986; 163:1162-72.
8. Toossi Z, Gogate P, Shiratsuchi H, Young T, Ellner JJ. Enhanced production of TGF-β by blood monocytes from patients with active tuberculosis and presence of TGF-β in tuberculosis granulomatous lung lesions. J Immunol 1995; 154:465-73.
9. Shimokata K, Saka H, Murate T, Hasegawa Y, Hasegawa T. Cytokine content in pleural effusion. Comparison between tuberculous and carcinomatous pleurisy. Chest 1991; 99:1103-7.
10. Schauf V, Rom WN, Smith KA et al. Cytokine gene activation and modified responsiveness to interleukin-2 in the blood of tuberculosis patients. J Infect Dis 1993; 168:1056-9.
11. Zhang M, Gately MK, Wang E et al. Interleukin 12 at the site of disease in tuberculosis. J Clin Invest 1994; 93:1733-9.
12. Barnes PF, Fong SJ, Brennan PJ, Twomey PE, Mazumder A, Modlin RL. Local production of tumor necrosis factor and IFN-γ in tuberculous pleuritis. J Immunol 1990; 145:149-54.
13. Lucivero G, Pierucci G, Bonomo L. Lymphocyte subsets in peripheral blood and pleural fluid. Eur Respir J 1988; 1:337-40.
14. Wada M. Flow cytometric analysis of peripheral T lymphocytes from patients with mycobacterial diseases. Kekkaku 1992; 67:393-407.
15. Lucas S, Nelson AM. Pathogenesis of tuberculosis in human immunodeficiency virus-infected people. In: Bloom BR, ed. Tuberculosis: pathogenesis, protection and control. Washington DC: American Society for Microbiology, 1994: 503-13.
16. Eriki PP, Okwera A, Aisu T, Morrissey AB, Ellner JJ, Daniel TM. The influence of human immunodeficiency virus infection on tuberculosis in Kampala, Uganda. Am Rev Respir Dis 1991; 143:185-7.
17. Lederman MM, Georges DL, Kusner DJ, Mudido P, Giam CZ, Toossi Z. Mycobacterium tuberculosis and its purified protein derivative activate expression of the human immunodeficiency virus. J Acquir Immun Defic Syndr 1994; 7:727-33.
18. Toossi Z, Sierra-Madero JG, Blinkhorn RA, Mettler MA, Rich EA. Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus type 1. J Exp Med 1993; 177:1511-6.
19. Erbe DV, Collins JE, Shen L, Graziano RF, Fanger MW. The effect of cytokines on the expression and function of Fc receptors for IgG on human myeloid cells. Molec Immunol 1990; 27:57-67.
20. Welch GR, Wong HL, Wahl SM. Selective induction of FcγRIII on human monocytes by transforming growth factor-β. J Immunol 1990; 144:3444-8.
21. Braakman E, van de Winkel JGJ, van Krimpen BA, Jansze M, Bolhuis RLH. CD16 on human γδ T lymphocytes: expression, function and specificity for mouse IgG isotypes. Cell Immunol 1992; 143:97-107.
22. Nagler A, Lanier LL, Cwirla S, Phillips JH. Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol 1989; 143:3183-91.
23. Tatsumi E, Kimura K, Takiuchi Y et al. T-lymphocytes expressing human Ia-like antigen in infectious mononucleosis (IM). Blood 1980; 56:383-7.
24. Peakman M, Warnock T, Vats A et al. Lymphocyte subset abnormalities, autoantibodies and their relationship with HLA DR types in children with types 1 (insulin-dependent) diabetes and their first degree relatives. Diabetologia 1994; 37:155-65.
25. Kestens L, Vanham G, Gigase P et al. Expression of activation antigens, HLA-DR and CD38 on CD8 lymphocytes during HIV-1 infection. AIDS 1992;6:793-7.
26. + T lymphocytes during HIV-1 infection. Clin Exp Immunol 1994; 95:436-41.
27. Locher C, Vanham G, Kestens L et al. Expression patterns of Fc gamma receptors, HLA-DR and selected adhesion molecules on monocytes from normal and HIV-infected individuals. Clin Exp Immunol 1994;98:115-22.
28. + blood monocytes is expanded in sepsis patients. Blood 1993; 82:3170-6.
29. Wallis RS, Ellner JJ. Cytokines and tuberculosis. J Leukocyte Biol 1994;55:676-81.
30. Valone SE, Rich EA, Wallis RS, Ellner JJ. Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens. Infect Immun 1988;56:3313-5.
31. Wallis RS, Amir-Tahmasseb M, Ellner JJ. Induction of IL-1 and TNF by mycobacterial proteins. Proc Natl Acad Sci USA 1990; 87:3348-52
32. Huber C, Batchelor JR, Fuchs D et al. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med 1984; 160:310-6.
33. 2-microglobulin in HIV-1 associated tuberculosis. J Infect Dis 1993; 167:43-48.
34. Rich EA, Tweardy DJ, Fujiwara H, Ellner JJ. Spectrum of immunoregulatory functions and properties of human alveolar macrophages. Am Rev Respir Dis 1987; 136:258-65.
35. Schauble TL, Boom WH, Finegan CK, Rich EA. Characterization of suppressor function of human alveolar macrophages for T lymphocyte responses to phytohemagglutinin: cellular selectivity, reversibility, and early events in T cell activation. Am J Respir Cell Mol Biol 1993; 8:89-97.
36. +CD25 T-cell population. J Immunol 1990; 144:1696-704.
37. + T cells from HIV-infected persons. J Immunol 1994; 153:412-20.
38. + T cells from HIV-infected subjects. Clin Exp Immunol 1995; 100:425-33.
39. Robinson WEJ, Montefiori DC, Mitchell WM. Antibody-dependent enhancement of human immunodeficiency virus type 1 infection. Lancet 1988; i:790-4.
40. Takeda A, Tuazon CU, Ennis FA. Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science 1988; 242:580-3.
41. Perno CF, Baseler MW, Broder S, Yarchoan R. Infection of monocytes by human immunodeficiency virus type 1 blocked by inhibitors of CD4 gp120 binding, even in the presence of enhancing antibodies. J Exp Med 1990; 171:1043-56.
42. Connor RI, Dinces NB, Howell AL, Romet-Lemonne JL, Pasquali JL, Fanger MW. Fc receptors for IgG (FcγRs) on human monocytes and macrophages are not infectivity receptors for human immunodeficiency virus type-1 (HIV-1) - studies using bispecific antibodies to target HIV-1. Proc Natl Acad Sci USA 1991; 21: 9593-7.
43. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen ISY. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 1990; 61:213-22.
44. + and CD25 T-cells in acute HIV infection in vitro. J Immunol 1993; 150:5202-8.
45. Clouse KA, Powell D, Washington I et al. Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. J Immunol 1989; 142:431-8.
46. + T-cells, but not by rIFNβ, rIFMγ, or recombinant tumor necrosis factor α. J Acquir Immun Defic Syndr 1991; 4:480-8.